Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934

For the month of November 2024

Commission File Number: 001-33768

AIX INC.

60/F, Pearl River Tower
No.15 West Zhujiang Road
Tianhe District, Guangzhou 510623
People’s Republic of China
(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	AIX Inc.

	By:	/s/ Yinan Hu
	Name:	Yinan Hu
	Title:	Chief Executive Officer

Date: November 29, 2024

Exhibit Index

Exhibit No.		Description.
Exhibit 99.1		Press Release
Exhibit 99.2		Transaction Agreement dated as of November 27, 2024, entered and made among BGM Group Ltd, CISG Holding Ltd, Patriton Limited, GM Management Company Limited, DuXiaoBao Intelligent Technology (Shenzhen) Co., Ltd., RONS Intelligent Technology (Beijing) Co., Ltd., Shenzhen Xinbao Investment Management Co., Ltd., Fanhua RONS Insurance Sales & Service Co., Ltd. and Shenzhen Baowang E-commerce Co., Ltd.

Exhibit 99.1

IR-407

AIX and BGM Group Forge Strategic Deal, Leading Healthcare, Pharma, and Insurance Industry Expansion with AI

GUANGZHOU, China, November 29, 2024 (GLOBE NEWSWIRE) -- AIX Inc. (Nasdaq: AIFU) (the “Company” or “AIX”), a leading independent technology-driven financial services provider in China, today announced that it has entered into a strategic transaction agreement (the “Agreement”) with BGM Group Ltd. (Nasdaq:BGM) (“BGM”), a leading global provider of premium pharmaceutical products and services. Pursuant to the Agreement, AIX agreed to transfer the equity interests of its intelligent platform consisting of RONS Intelligent Technology (Beijing) Co., Ltd. (“RONS Technology”) and Shenzhen Xinbao Investment Management Co., Ltd. (“Xinbao Investment”), valued at approximately US$140.0 million, to BGM in exchange for 69,995,661 of BGM’s Class A ordinary shares, at a consideration valuation of US$2.00 per share.

The transaction is expected to close by the end of 2024, subject to certain closing conditions. Upon completion of the transaction, AIX will hold approximately 72.0% of BGM’s equity interests and approximately 3.4% of its voting power while BGM will gain full control of RONS Technology and Xinbao Investment.

The Company anticipates that RONS Technology and Xinbao Investment will both gain broader development opportunities through this transaction. BGM’s extensive resources in the healthcare sector will create more application scenarios for both parties’ products and services, further unlocking their growth potential. AIX, through its shareholding in BGM, will indirectly participate in the value creation of RONS Technology and Xinbao Investment, ensuring that its shareholders can continue to benefit from their future value growth.

Additionally, this transaction will accelerate AIX’s strategic expansion into the pharmaceutical and healthcare sector. This will enable the Company to fully capitalize on the opportunities brought by the aging population and the silver economy in China, injecting new momentum into the company’s future growth.

Mr. Yinan Hu, Chief Executive Officer of AIX, commented: “AI-driven innovation is the future of the insurance industry. Our platform has already shown tremendous potential within the insurance sector, but achieving broader growth requires a more open perspective and stronger ecosystem support. We believe this partnership with BGM will allow our intelligent platform to reach a broader user base and unleashes the potential of AI technologies beyond insurance.

IR-407

“This collaboration represents an important milestone in our strategic transformation. BGM, as a leading global player in the pharmaceutical industry, brings deep expertise, an international perspective, and a solid industry position, all of which will help fuel the development of our intelligent platform in the pharmaceutical and healthcare sectors. With this partnership, we will be able to expand our intelligent capabilities from insurance to the pharmaceutical and healthcare industries to seize opportunities in the silver economy, and foster higher-quality development.

“We will continue to be a key user of the intelligent platform and actively invest resources to unlock its technological potential. We firmly believe that this partnership will unlock immense opportunities for both AIX and our intelligent platform while delivering greater long-term value to our clients, partners and shareholders.”

Mr. Chen Xin, Chief Executive Officer of BGM, stated, “We are deeply impressed by AIX’s achievements in digitalization and intelligent transformation. Their expertise and technological advancements offer valuable insights for advancing our intelligent transformation in the healthcare and pharmaceutical sectors. We believe that this partnership will not only strengthen our technological competitiveness but also accelerate our strategic positioning, enabling us to provide more efficient and intelligent solutions to the global market. I look forward to a mutually beneficial collaboration that will shape the future of both parties.”

BGM operates through its subsidiary Gansu Qilianshan Pharmaceutical Co., Ltd. and its affiliates. Since its inception in 1969, BGM has evolved into a leading provider of premium products and services within the global pharmaceutical industry, skillfully harnessing over 50 years of cutting-edge biotechnological production expertise in bio-fermentation, bio-extraction, and pharmaceutical formulation. BGM has established a strong position in the international pharmaceutical industry through extensive pharmaceutical experience, innovative technique, and expansion into global markets.

Founded in 2009, RONS Technology, a wholly-owned subsidiary of AIX, specializes in developing digital and intelligent technologies for the financial and insurance industries. RONS Technology boasts extensive experience in insurtech, having introduced disruptive innovations through its RONS Open Platform and flagship product Du Xiaobao. RONS Technology has steadily built a strong presence within the insurtech landscape, offering substantial growth potential and development opportunities.

Established in 2004, Xinbao Investment, an affiliate under AIX’s control, has developed a professional integrated online and offline insurance trading and service platform known as “Baowang”. Baowang provides comprehensive risk protection solutions for individuals, families, and small to medium-sized enterprises through the integration of technology, products, and services. The platform currently offers over 300 flagship products from more than 30 insurance companies, addressing various protection needs such as critical illness, term life, accident, health, travel, and corporate insurance.

IR-407

About AIX Inc.

AIX, established in 1998, is a leading intelligent technology-driven independent financial services provider in China. It provides 400 million middle-class families with insurance protection, wealth management, and value-added services and provides independent financial advisors and various insurance/financial sales organizations with technical support and comprehensive solutions. Through AI-driven insights and cutting-edge digital tools, AIX has successfully established itself as a leader in intelligent transformation within the financial services industry.

Forward-looking Statements

This press release contains statements of a forward-looking nature. These statements, including the statements relating to the Company’s future financial and operating results, are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. You can identify these forward-looking statements by terminology such as “will”, “expects”, “believes”, “anticipates”, “intends”, “estimates” and similar statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations, assumptions, estimates and projections about AIX Inc. and the industry. Potential risks and uncertainties include, but are not limited to, those relating to its ability to attract and retain productive agents, especially entrepreneurial agents, its ability to maintain existing and develop new business relationships with insurance companies, its ability to execute its growth strategy, its ability to adapt to the evolving regulatory environment in the Chinese insurance industry, its ability to compete effectively against its competitors, quarterly variations in its operating results caused by factors beyond its control including macroeconomic conditions in China. Except as otherwise indicated, all information provided in this press release speaks as of the date hereof, and AIX Inc. undertakes no obligation to update any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although AIX Inc. believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that its expectations will turn out to be correct, and investors are cautioned that actual results may differ materially from the anticipated results. Further information regarding risks and uncertainties faced by AIX Inc. is included in AIX Inc.’s filings with the U.S. Securities and Exchange Commission, including its annual report on Form 20-F.

For more information, please contact:

AIX Inc.

Investor Relations

Tel: +86 (20) 8388-3191

Email: ir@aifugroup.com

Exhibit 99.2

TRANSACTION AGREEMENT

BY AND AMONG

BGM GROUP LTD,

CISG HOLDING LTD,

PATRITION LIMITED,

GM MANAGEMENT COMPANY LIMITED,

DUXIAOBAO INTELLIGENT TECHNOLOGY (SHENZHEN) CO., LTD
(度晓保智能科技(深圳)有限公司)

RONS INTELLIGENT TECHNOLOGY (BEIJING) CO., LTD.
(榕数智能科技（北京）有限公司),

AND

THE OTHER PARTIES NAMED HEREIN

DATED AS OF November 27, 2024

TABLE OF CONTENTS

		Page
RECITALS		1

Article 1 Definitions and Interpretation		2

Section 1.1.	Definitions.	2

Section 1.2.	Interpretation.	7

Article 2 Share Exchange		8

Section 2.1.	Share Exchange.	8

Section 2.2.	Closing.	8

Article 3 Representations and Warranties of the Buyer		10

Section 3.1.	Accuracy of Disclosure.	10

Section 3.2.	Existence and Power.	10

Section 3.3.	Authorization; Due Execution.	10

Section 3.4.	No Conflicts.	11

Section 3.5.	Capitalization.	11

Section 3.6.	Subsidiaries.	12

Section 3.7.	Compliance with Laws.	12

Section 3.8.	Governmental Approvals.	12

Section 3.9.	Financial Matters.	12

Section 3.10.	Operations.	13

Section 3.11.	Absence of Certain Changes.	13

Section 3.12.	Litigation.	13

Section 3.13.	Bankruptcy.	13

Section 3.14.	Brokers’ Fees.	13

Section 3.15.	No Buyer Material Adverse Effect.	14

Section 3.16.	Independent Investigation.	14

Article 4 Representations and Warranties of the Seller		14

Section 4.1.	Accuracy of Disclosure.	14

Section 4.2.	Existence and Power.	14

Section 4.3.	Authorization; Due Execution.	15

Section 4.4.	No Conflicts.	15

Section 4.5.	Capitalization.	15

Section 4.6.	Subsidiaries.	16

Section 4.7.	Compliance with Laws.	16

Section 4.8.	Governmental Approvals.	16

Section 4.9.	Financial Matters.	16

Section 4.10.	Operations.	17

Section 4.11.	Absence of Certain Changes.	17

Section 4.12.	Litigation.	17

Section 4.13.	Bankruptcy.	17

Section 4.14.	Brokers’ Fees.	17

Section 4.15.	No Target Co. Material Adverse Effect.	17

Section 4.16.	Independent Investigation.	18

Article 5 Conditions		18

Section 5.1.	Conditions to the Obligation of the Seller and the Buyer to Consummate Closing.	18

Section 5.2.	Other Conditions to the Obligation of the Seller to Consummate the Closing.	18

Section 5.3.	Other Conditions to the Obligation of the Buyer to Consummate the Closing.	19

Article 6 Covenants		20

Section 6.1.	Conduct of Business Pending the Closing.	20

Section 6.2.	Notification.	20

Section 6.3.	Required Consents; Communications with Governmental Authorities.	21

Section 6.4.	Confidentiality.	22

Section 6.5.	Further Assurances.	22

Section 6.6.	Public Announcements.	22

Section 6.7.	Tax.	23

Section 6.8.	Non-Competition.	23

Section 6.9.	Performance.	23

Section 6.10.	Lock-Up.	24

Article 7 Indemnification		24

Section 7.1.	Survival.	24

Section 7.2.	Indemnification by the Buyer.	25

Section 7.3.	Limits on Indemnification by the Buyer.	25

Section 7.4.	Indemnification by the Seller.	26

Section 7.5.	Limits on Indemnification by the Seller.	26

Section 7.6.	Mitigation.	27

Section 7.7.	Sole Remedy; Specific Performance.	27

Section 7.8.	Third Party Claims.	27

Article 8 Termination		28

Section 8.1.	Termination Rights.	28

Section 8.2.	Effects.	28

Article 9 Miscellaneous		29

Section 9.1.	Entire Agreement.	29

Section 9.2.	Notices.	29

Section 9.3.	Amendment; Waiver.	30

Section 9.4.	Severability.	31

Section 9.5.	Non-assignment.	31

Section 9.6.	Governing Law.	31

Section 9.7.	Dispute Resolution.	31

Section 9.8.	Performance Pending Dispute Resolution.	32

Section 9.9.	Specific Performance.	32

Section 9.10.	Counterparts.	32

Section 9.11.	Third-Party Beneficiaries.	32

Section 9.12.	Expenses.	32

EXHIBIT A INSTRUMENT OF TRANSFER

EXHIBIT B EQUITY TRANSFER AGREEMENT

iii

TRANSACTION AGREEMENT

This TRANSACTION AGREEMENT (as may be amended, restated, supplemented or varied in accordance with the terms herein, this “Agreement”) is entered into and effective as of November 27, 2024, by and among:

(1)

BGM Group Ltd, an exempted company with limited liability duly incorporated under the laws of the Cayman Islands (the “Buyer”);

(2)

CISG Holding Ltd, a business company duly incorporated under the laws of the British Virgin Islands (the “Seller”);

(3)

Patriton Limited, a business company duly incorporated under the laws of the British Virgin Islands (“Target Co.”);

(4)

GM Management Company Limited, a company duly incorporated under the laws of Hong Kong (the “HK Co.”);

(5)

DuXiaoBao Intelligent Technology (Shenzhen) Co., Ltd. (度晓保智能科技（深圳）有限公司), a limited liability company duly incorporated under the laws of the PRC (the “WFOE”) to set up;

(6)

RONS Intelligent Technology (Beijing) Co., Ltd. (榕数智能科技（北京）有限公司), a limited liability company duly incorporated under the laws of the PRC (“RONS Intelligent”);

(7)

Shenzhen Xinbao Investment Management Co., Ltd. (深圳市新保投资管理有限公司), a limited liability company duly incorporated under the laws of the PRC (“Shenzhen Xinbao”);

(8)

Fanhua RONS Insurance Sales & Service Co., Ltd. (泛华榕数保险销售服务有限公司), a limited liability company duly incorporated under the laws of the PRC (“RONS Sales”); and

(9)

Shenzhen Baowang E-commerce Co., Ltd. (深圳市保网电子商务有限公司), a limited liability company duly incorporated under the laws of the PRC (“Shenzhen Baowang”).

Each of the parties to this Agreement is referred to herein individually as a “Party” and collectively as the “Parties”.

RECITALS

WHEREAS, as of the date of this Agreement, the Seller owns 50,000 ordinary shares of Target Co. with par value of US$1.0 per share (such shares, the “Sale Shares”), which constitute all of the issued and outstanding equity securities of Target Co..

WHEREAS, the Seller and the other relevant parties intends to conduct a series of restructuring and reorganization arrangements (collectively, the “Reorganization”), such that, after the completion of the Reorganization and immediately prior the Closing, each of RONS Intelligent, Shenzhen Xinbao, RONS Sales and Shenzhen Baowang shall be the wholly Subsidiary of Target Co.

WHEREAS, the Seller desires to sell, transfer and deliver all of the Sale Shares to the Buyer, and the Buyer desires to issue 69,995,661 Buyer Shares (as defined below) (the number of such Buy Shares shall be the result of dividing (x) the US$ amount equivalent of RMB1,000,000,000 (the exchange rate of RMB against US$ shall be the central parity rate as published by China Foreign Exchange Trading Center and authorized by the People’s Bank of China on date of November 8, 2024, i.e., US$1.0 against RMB7.1433) by (y) the purchase price per share of US$2.0, as appropriately adjusted for any share split, consolidation, subdivision, reclassification, recapitalization or similar arrangement, if any) (such shares, the “Consideration Shares”) in exchange for the Sale Shares, pursuant to the terms and subject to the conditions set forth in this Agreement.

WHEREAS, the Parties desire to make certain representations, warranties, covenants and agreements in connection with this Agreement and the transactions contemplated hereby and to prescribe certain conditions with respect to the consummation of the transactions contemplated by this Agreement.

NOW THEREFORE, in consideration of the premises set forth above and the Parties’ respective representations, warranties, covenants and agreements contained in this Agreement, as well as other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:

Article 1
Definitions and Interpretation

Section 1.1. Definitions.

For the purposes of this Agreement, in addition to the words and expressions defined elsewhere in this Agreement, the following terms shall have the following meanings:

“Affiliate” means, (a) with respect to any Person that is a natural person, (i) any other Person that is directly or indirectly Controlled by such Person, (ii) such Person’s spouse, lineal descendant (whether natural or adopted), brother, sister, or parent, and/or (iii) any estate, trust or partnership that is established by or for the benefit of such Person or any Person described in (ii), in each case, that is directly or indirectly Controlled by such Person, and (b) with respect to any Person that is not a natural person, any other Person that is directly or indirectly Controlling, Controlled by or under common Control with such Person. For the avoidance of doubt, any Buyer Group Company shall not be deemed to be an Affiliate of any Target Co. Group Company, and any Target Co. Group Company shall not be deemed to be an Affiliate of any Buyer Group Company.

“Applicable Law” means any transnational, foreign or domestic federal, provincial, state or local law, statute, ordinance, treaty, constitution, regulation, rule, code, Order, authoritative interpretation or other requirement or rule of law, including common law, as may be applicable.

“Approvals” means any license, consent, authorization, order, confirmation, qualification, permission, certificate, approval, authorization, record-filing, registration, permit, waiver and/or exemption.

“Business Day” means a day, other than Saturday, Sunday or any other day on which commercial banks in Hong Kong, the PRC, the British Virgin Islands, are authorized or required by Applicable Laws to close.

“Buyer Group Companies” means the Buyer and its Subsidiaries from time to time, and each a “Buyer Group Company”.

“Buyer Material Adverse Effect” means any event, circumstance, development, change or effect that, individually or in the aggregate, has or would reasonably be expected to have a material adverse effect on (a) the business, properties, assets, Liabilities, operations, results of operations or financial condition of the Buyer Group Companies, taken as a whole, or (b) the authority or ability of the Buyer to perform its obligations under this Agreement or any of the Transaction Agreements; provided, however, that for purposes of clause (a) above, in no event shall any of the following exceptions, alone or in combination with the other enumerated exceptions below, be deemed to constitute, a Buyer Material Adverse Effect: (i) any effect resulting from compliance with the terms and conditions of, or from the announcement of the transactions contemplated by this Agreement and/or any Transaction Agreement, (ii) any effect that results from changes affecting the industries in which the Buyer or the Buyer Group Companies operate generally, (iii) any effect that results from changes affecting general worldwide economic conditions, provided that any such changes in (ii) and (iii) do not disproportionately affect the Buyer Group Companies, taken as a whole, in any material respect relative to other similarly situated participants in the industry in which they operate, with comparable business volume and similar development stage, (iv) any pandemic, earthquake, typhoon, tornado or other natural disaster or similar force majeure event, or (v) any failure to meet any internal or public projections, forecasts or guidance, provided that the underlying causes that lead to any failure to meet any internal or public projections, forecasts or guidance as set forth in (v) are not included under this clause (v).

“Buyer Public Reports” means the annual reports of the Buyer for the financial years ended September 30, 2022 and 2023 , and the financial reports of the Buyer for October 1, 2023, to March 31, 2024, respectively, as publicly filed by the Buyer with SEC.

“Buyer Shares” means the class A ordinary shares of BGM Group Ltd, par value US$0.00833335 per share (or of such other securities as shall result from a subdivision, consolidation, re-classification or re-construction of such shares from time to time)

“Target Co. Group Companies” means Target Co. and its Subsidiaries from time to time, for the avoidance of doubt, after the completion of the Reorganization and immediately prior the Closing, including RONS Intelligent, Shenzhen Xinbao, RONS Sales and Shenzhen Baowang, and each a “Target Co. Group Company”.

“Target Co. Material Adverse Effect” means any event, circumstance, development, change or effect that, individually or in the aggregate, has or would reasonably be expected to have a material adverse effect on (a) the business, properties, assets, Liabilities, operations, results of operations or financial condition of the Target Co. Group Companies, taken as a whole, or (b) the authority or ability of Target Co. to perform its obligations under this Agreement or any of the Transaction Agreements; provided, however, that for purposes of clause (a) above, in no event shall any of the following exceptions, alone or in combination with the other enumerated exceptions below, be deemed to constitute, a Target Co. Material Adverse Effect: (i) any effect resulting from compliance with the terms and conditions of, or from the announcement of the transactions contemplated by this Agreement and/or any Transaction Agreement, (ii) any effect that results from changes affecting the industries in which Target Co. or the Target Co. Group Companies operate generally, (iii) any effect that results from changes affecting general worldwide economic conditions, provided that any such changes in (ii) and (iii) do not disproportionately affect the Target Co. Group Companies, taken as a whole, in any material respect relative to other similarly situated participants in the industry, in which they operate with comparable business volume and similar development stage, (iv) any pandemic, earthquake, typhoon, tornado or other natural disaster or similar force majeure event, or (v) any failure to meet any internal or public projections, forecasts or guidance, provided that the underlying causes that lead to any failure to meet any internal or public projections, forecasts or guidance as set forth in (v) are not included under this clause (v).

“Control” means, as to any Person, the power to direct or cause the direction of the management and policies of such Person, whether through the ownership of voting securities, by contract or otherwise. The terms “Controlled by”, “Controlled” and “Controlling” shall have correlative meanings.

“CSRC Filing” means the filing (including any amendments, supplements and/or modifications thereof) in relation to the issuance, allotment and delivery of the Consideration Shares and any Transactions and any relevant supporting materials (including the PRC legal opinion to be issued by the counsel for the Buyer on the PRC laws, where applicable) with the CSRC pursuant to the applicable requirements under the Trial Administrative Measures of Overseas Securities Offering and Listing by Domestic Companies (境内企业境外发行证券和上市管理试行办法) and supporting guidelines issued by the CSRC on 17 February 2023 (as amended, supplemented or otherwise modified from time to time).

“CSRC” means the China Securities Regulatory Commission.

“Fundamental Buyer Representations” means the representations and warranties by Buyer in Section 3.2, Section 3.3, Section 3.4, Section 3.5, Section 3.7(b), Section 3.13, and Section 3.15.

“Fundamental Seller Representations” means the representations and warranties by the Seller in Section 4.2, Section 4.3, Section 4.4, Section 4.5, Section 4.13 and Section 4.15.

“Governmental Authority” means any international, transnational, national, domestic or foreign, federal, state, prefecture, regional or local government, department, division or subdivision, governmental, regulatory or administrative agency, administration, board, authority, commission, instrumentality or other body, self-regulatory organization or any court, tribunal or other judicial or arbitral body, or any governing body of a stock exchange.

“Hong Kong” means the Hong Kong Special Administrative Region of the PRC.

“Indemnifying Party” means the Buyer pursuant to Section 7.2, and the Seller pursuant to Section 7.4, as the case may be.

“Intellectual Property” means any intellectual property or similar proprietary rights, including all trademarks, service marks, business or trade names, trading goodwill, Internet domain names, social media identifiers or accounts, designs (whether registered or unregistered), patents, copyrights, database rights, confidential information, trade secrets, know-how and all registrations and applications for registration of any of the foregoing.

“Knowledge” shall mean, with respect to any Person, the actual knowledge of such Person, and that knowledge which should have been acquired by such Person after making such due inquiry and exercising such due diligence as a prudent business person would have made or exercised in the management of his or her business affairs.

“Liability” means any liability or obligation of any kind or description, whether accrued, contingent, absolute, determined, determinable, known, unknown or otherwise, and whether presently in existence as of the date of this Agreement or arising hereafter.

“Lien” means any charge, debenture, lien, mortgage, security interest, pledge deposit, encumbrance, assignment, hypothecation, title retention, right of pre-emption, assignment, deed of trust, other security agreement or arrangement or other type of preferential arrangement having similar effect, any voting proxy, power of attorney, voting trust arrangement, interest, exclusive license of Intellectual Property, right of first refusal or any adverse claim as to title, possession or use and all other rights or interests exercisable by, or claims by, third parties, irrespective of whether such Lien arises under any agreement or other instrument, operation of law or by means of a judgment, order or decree of any Governmental Authority.

“Long Stop Date” means the six (6) -month anniversary of the date of this Agreement or other date that is agreed upon in writing by the Seller and the Buyer after the initial six (6)-month anniversary.

“NASDAQ” means the Nasdaq Capital Market.

“Order” means any order, writ, judgment, injunction, decree, stipulation, ruling, decision, verdict, determination or award made, issued or entered by or with any Governmental Authority.

“Organizational Documents” means, with respect to any Person (other than an individual), (a) the memorandum, certificate of incorporation, articles of association or any other similar documents adopted or filed in connection with the creation, formation or organization of such Person and (b) the by-laws, voting agreements and similar documents, instruments or agreements relating to the organization or governance of such Person, in each case, as amended, supplemented or restated from time to time.

“Person” means any individual, partnership, corporation, company, limited liability company, firm, association, joint-stock company, trust, joint venture, unincorporated organization, institution, trust or agency, Governmental Authority or other entity of any kind, whether or not having a separate legal personality.

“PRC” means the People’s Republic of China, excluding, for purposes of this Agreement, Hong Kong, Taiwan and Macau Special Administrative Region of the PRC.

“Proceeding” means any claim, demand, suit, litigation, arbitration, proceeding, audit or investigation brought by or before any Governmental Authority.

“SAMR” means the State Administration for Market Regulation of the PRC and its local branches.

“SEC Documents” means, collectively, all statements, reports, schedules, forms and other documents required to be filed or furnished by the Buyer or the Seller (as the case may be) to or with the SEC pursuant to the listing rules and regulations from time to time, together with all exhibits included therein and financial statements, notes and schedules thereto and documents incorporated by reference therein.

“SEC” means the U.S. Securities and Exchange Commission.

“Securities Act” means the U.S. Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

“Share Transfer” means the share transfer transaction under the Equity Transfer Agreement (as defined in the Equity Transfer Agreement as “本次股权转让”) (i.e., the shareholder of RONS Intelligent transfer 100% equity interests of RONS Intelligent (representing registered capital of RMB 20,000,000 of RONS Intelligent) to the transferee designated by the Buyer pursuant to the terms and conditions under the Equity Transfer Agreement).

“Subsidiary” of a Person means any other Person that is Controlled by the first-mentioned Person.

“Tax Return” means any return, declaration, report, claim for refund, information return or statement or other document required to be filed with respect to tax, including any schedule or attachment thereto, and including any amendment thereof.

“Transaction Documents” means this Agreement, any instrument of transfer substantially in the form of Exhibit A, the equity transfer agreement (股权转让协议) substantially in the form of Exhibit B (such agreement, the “Equity Transfer Agreement”), and any other agreement, document or instrument entered into or delivered in connection with the transactions contemplated hereby or thereby.

“US$” or “$” or “USD” means the United States dollar, the lawful currency of the United States.

“¥” or “RMB” means the renminbi, the lawful currency of the PRC.

Section 1.2. Interpretation.

This Agreement shall be construed according to its fair language. The rule of construction to the effect that ambiguities are to be resolved against the drafting party shall not be employed in interpreting this Agreement. For the purposes of this Agreement, the words “hereof”, “herein” and “hereunder” and words of like import used in this Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement. The captions herein are included for convenience of reference only and shall be ignored in the construction or interpretation hereof. References to Articles, Sections, Exhibits and Schedules are to Articles, Sections, Exhibits and Schedules of this Agreement unless otherwise specified. All Exhibits and Schedules annexed hereto or referred to herein are hereby incorporated in and made a part of this Agreement as if set forth in full herein. Any capitalized terms used in any Exhibit or Schedule but not otherwise defined therein shall have the meaning as defined in this Agreement. Any singular term in this Agreement shall be deemed to include the plural, and any plural term the singular. Whenever the words “include”, “includes” or “including” are used in this Agreement, they shall be deemed to be followed by the words “without limitation”, whether or not they are in fact followed by those words or words of like import. “Writing”, “written” and comparable terms refer to printing, typing and other means of reproducing words (including email and other electronic media) in a visible form. References to any agreement or contract are to that agreement or contract as amended, modified or supplemented from time to time in accordance with the terms hereof and thereof. References to any law include all rules and regulations promulgated thereunder and as amended, modified or supplemented from time to time. References to any Person include the successors and permitted assigns of that Person. References from or through any date mean, unless otherwise specified, from and including or through and including, respectively, and any time of day is a reference to China Standard Time (unless otherwise specified), and if the date on or by which something must be done is not a Business Day, that thing must be done on or by the Business Day immediately following such day.

Article 2
Share Exchange

Section 2.1. Share Exchange.

Subject to the terms and conditions hereof, the Seller agree to sell, transfer and deliver to the Buyer, at the Closing, all of the Sale Shares, free and clear of all Liens and together with all rights attached or accruing to them at the Closing Date (as defined below), and the Buyer agrees to issue to the Seller, at the Closing, all of the Consideration Shares free and clear of all Liens and together with all rights attached or accruing to them at the Closing Date (such transaction, the “Share Exchange”).

Section 2.2. Closing.

(a) The closing of the Share Exchange (the “Closing”, and the date on which the Closing occurs, the “Closing Date”) shall take place via the remote exchange of documents and signatures on a date as soon as possible but in any event no later than the fifth (5th) Business Day after the satisfaction or valid waiver by the relevant Party of each of the conditions set forth in Section 5.1, Section 5.2 and Section 5.3 (except for the conditions that by their nature are to be satisfied at the Closing, but subject to the satisfaction or waiver of those conditions at the Closing), or at such other time and place as collectively agreed by the Buyer and the Seller.

(b) Notwithstanding the foregoing, the Closing of the Share Exchange and the closing of the Share Transfer (as defined in the Equity Transfer Agreement as “交割”) shall occur concurrently.

(i) all of the Consideration Shares and the scanned copy of share certificate(s) representing the Consideration Shares, duly executed on behalf of the Buyer and registered in the name of the Seller, the original copy of which shall be delivered to the Seller within five (5) Business Days following the Closing Date;

(ii) a certified true copy of an excerpt of the register of members of the Buyer, reflecting the Seller’s ownership of the Consideration Shares;

(iii) a scanned copy of the board of directors’ resolutions of the Buyer, approving and consenting to, among other things, the execution, delivery and performance of this Agreement and any other Transaction Document to which the Buyer is a party, and the transactions contemplated hereby and thereby;

(iv) a receipt issued by the CSRC or other proof reasonably satisfactory to the Seller, which shall evidence that, the CSRC Filling have been duly submitted by the Buyer and accepted by the CSRC on the Closing Date; and

(v) a certificate executed by a duly authorized officer of the Buyer, certifying to the fulfillment of the conditions specified in Section 5.1 and Section 5.2;

(vi) to the extent not previously delivered, such documents, instruments and items required to be delivered in connection with the fulfillment of the conditions specified in Section 5.1 and Section 5.2.

(d) At the Closing, the Seller shall deliver or cause to be delivered to the Buyer:

(i) all of the Sale Shares, and the scanned copy of share certificate(s) representing the Sale Shares, duly executed on behalf of Target Co. and registered in the name of the Buyer, the original copy of which shall be delivered to the Buyer within five (5) Business Days following the Closing Date;

(ii) a certified true copy of the register of members of Target Co., reflecting the Buyer’s ownership of the Sale Shares;

(iii) a scanned copy of the resignation letters duly executed by such director(s) of Target Co. nominated by the Seller, the original copy of which shall be delivered to Target Co.’s registered agent within five (5) Business Days following the Closing Date;

(iv) a scanned copy of the instrument of transfer evidencing the transfer of the Sale Shares to the Buyer, substantially in the form of Exhibit A, duly executed by the Seller, the original copy of which shall be delivered to Target Co.’s registered agent within five (5) Business Days following the Closing Date;

(v) a scanned copy of the directors’ resolutions of the Seller, approving and consenting to, among other things, the execution, delivery and performance of this Agreement and any other Transaction Document to which the Seller is a party, and the transactions contemplated hereby and thereby;

(vi) a certificate executed by a duly authorized officer of the Seller, certifying to the fulfillment of the conditions specified in Section 5.1 and Section 5.3; and

(vii) to the extent not previously delivered, such documents, instruments and items required to be delivered in connection with the fulfillment of the conditions specified in Section 5.1 and Section 5.3.

(e) At the Closing, the Seller shall, and shall cause the relevant Target Co. Group Companies to, deliver (or cause to be delivered) to the Buyer (i) all chops and seals of the Target Co. Group Companies, including all company chops, financial chops, contract chops and other chops and seals (if any), (ii) all books, accounts records, tax files, tax reports and any other similar documents of the Target Co. Group Companies, (iii) all documents necessary to change the bank mandates of the Target Co. Group Companies in such manner as the Buyer requires and all online banking u-keys of the Target Co. Group Companies, and (iv) all licenses, Permits, physical assets and contracts of the Target Co. Group Companies.

Article 3
Representations and Warranties of the Buyer

The Buyer hereby represents and warrants, as of the date hereof and as of the Closing Date, that each of the following statements is true and correct:

Section 3.1. Accuracy of Disclosure.

The Buyer has filed or furnished, as applicable, on a timely basis, all the SEC Documents. As of their respective effective dates (in the case of the SEC Documents that are registration statements filed pursuant to the requirements of the Securities Act) and as of their respective SEC filing dates (in the case of all other SEC Documents), or in each case, if amended prior to the date hereof, as of the date of the last such amendment: (a) each of the SEC Documents complied in all material respects with the applicable requirements of the listing and corporate governance rules and regulations, and (b) none of the SEC Documents contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the material statements therein, in the light of the circumstances under which they were made, not misleading.

Section 3.2. Existence and Power.

The Buyer is an entity duly organized or incorporated, validly existing and in good standing (to the extent such concept is applicable) under the laws of its jurisdiction of organization or incorporation and has full right, power and authority to execute and deliver this Agreement and each other Transaction Document to which it is or will be a party, to perform fully its obligations hereunder and thereunder and to consummate the transactions contemplated hereby and thereby. The Buyer has the requisite corporate power and authorization to own, lease and operate its properties and to carry on its business as now being conducted, except which have not had and would not constitute a Buyer Material Adverse Effect.

Section 3.3. Authorization; Due Execution.

The execution, delivery and performance by the Buyer of this Agreement and each other Transaction Document to which it is or will be a party and the consummation of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Buyer. The Buyer has duly executed and delivered this Agreement and each other Transaction Document to which it is a party, and this Agreement and each such other Transaction Document constitutes a legal, valid and binding obligation of the Buyer enforceable against it in accordance with its terms.

Section 3.4. No Conflicts.

The execution, delivery and performance by the Buyer of this Agreement and each other Transaction Document to which it is or will be a party and the consummation of the transactions contemplated hereby and thereby do not and will not (with or without the giving of notice, the lapse of time or both) conflict with or result in a violation or breach of, or default under, (a) the Organizational Documents of the Buyer; (b) any Applicable Laws to which the Buyer or any of its properties or assets is subject; (c) any contract, agreement or other instrument applicable to the Buyer or any of its properties or assets, except, in the case of clauses ‎(a) and ‎(b) above, to the extent that such conflict, violation, breach or default, individually or in the aggregate, has not impaired or delayed, and will not impair or delay, the ability of the Buyer to perform its obligations under this Agreement or any other Transaction Document to which it is a party or to consummate the transactions contemplated hereby or thereby.

Section 3.5. Capitalization.

(a) As of immediately prior to the Closing, the authorized share capital of the Buyer consists of $41,916,750.50 divided into 5,000,000,000 class A ordinary shares, 20,000,000 class B ordinary shares, and 10,000,000 preferred shares, of US$ 0.00833335 par value each, of which, 7,226,480 class A ordinary shares and 20,000,000 class B ordinary shares are issued and outstanding. All of the issued and outstanding shares of the Buyer are duly authorized, validly issued, fully paid and non-assessable.

(b) Except as otherwise set forth above in this Section 3.5, there are no outstanding (i) shares of capital stock or voting securities of the Buyer, (ii) securities of the Buyer (whether debt or equity) convertible into or exchangeable for shares of capital stock or voting securities of the Buyer, or (iii) preemptive or other outstanding rights, options, warrants, conversion rights, “phantom” stock rights, stock appreciation rights, redemption rights, repurchase rights, agreements, arrangements, calls, commitments or rights of any kind that obligate the Buyer to issue or sell any shares of capital stock or other securities of the Buyer or any securities or obligations convertible or exchangeable into or exercisable for, or giving any Person a right to subscribe for or acquire, any securities of the Buyer, and no securities or obligations evidencing such rights are authorized, issued or outstanding, or (iv) obligations of the Buyer to repurchase, redeem or otherwise acquire any capital stock or equity interests of the Buyer.

(c) The Buyer has sufficient authorized share capital to issue the Consideration Shares in accordance with this Agreement. The Consideration Shares when issued, allotted, transferred or exchanged, as the case may be, in accordance with the terms and for the consideration set forth in this Agreement, will be issued, allotted, transferred or exchanged, in compliance with Applicable Laws and Organizational Documents, duly authorized, validly issued, fully paid and non-assessable, free and clear of all Liens (except for Liens created or imposed by the Transaction Documents or under applicable securities Laws).

(d) The Issuance of the Consideration Shares shall not result in or reasonably expected to result in any change of Control of the Buyer.

Section 3.6. Subsidiaries.

Each Subsidiary of the Buyer has been duly organized, is validly existing and in good standing (to the extent such concept is applicable) under the laws of its jurisdiction of organization or incorporation, and has the requisite corporate power and authorization to own, lease and operate its properties and to carry on its business as now being conducted, except which have not had and would not constitute a Buyer Material Adverse Effect. Each Buyer Group Company is duly qualified or licensed to do business in each jurisdiction in which the property owned, leased or operated by it or the nature of the business conducted by it makes such qualification or licensing necessary, except where the failure to be so qualified or licensed would not, individually or in the aggregate, reasonably be expected to have a Buyer Material Adverse Effect.

Section 3.7. Compliance with Laws.

(a) The business of the Buyer and its Subsidiaries is being conducted, and has been conducted at any time during the three (3) years prior to the date hereof, in all material respects in accordance with their respective Applicable Laws and other requirements of all Governmental Authorities having jurisdiction over or otherwise applicable to each of the Buyer and its Subsidiaries except as would not, individually or in the aggregate, result in a Buyer Material Adverse Effect.

(b) The Buyer is, and the consummation of the transactions contemplated by this Agreement will be, in compliance in all material respects with the applicable listing and corporate governance rules and regulations of the SEC and NASDAQ. The Buyer has not taken any action designed to, or reasonably likely to have the effect of, delisting the Buyer ordinary shares from NASDAQ. The Buyer has not received from the SEC, NASDAQ, CSRC and/or any other competent Governmental Authority any notification that the SEC, NASDAQ, CSRC and/or any other competent Governmental Authority has determined or is proposing to suspend or terminate such listing.

Section 3.8. Governmental Approvals.

The execution, delivery and performance by the Buyer of this Agreement and any other Transaction Document to which it is or will be a party and the consummation of the transactions contemplated hereby and thereby do not and will not require any Approval issued or granted by, negative clearance from, or expiration or early termination of any waiting period imposed by, any Governmental Authority, except for the NASDAQ Listing Authorization (if applicable and necessary) and the CSRC Filing.

Section 3.9. Financial Matters.

(a) The financial statements included in the Buyer Public Reports present fairly and accurately the financial condition of the Buyer Group Companies as of the dates therein indicated and the results of operations for the period or periods therein specified, all in accordance with United States General Accepted Accounting Principle (“US GAAP”) on a consistent basis throughout the periods therein specified (except as otherwise noted therein). The information set forth in the Buyer Public Reports is true and accurate in all material respects.

(b) Except as disclosed in the Buyer Public Reports, none of the Buyer Group Companies is a guarantor or indemnitor of any indebtedness of any other person or entity, nor any Buyer Group Company has any indebtedness or liability (contingent or otherwise) that it has directly or indirectly created, incurred, assumed, or guaranteed, or with respect to which such Buyer Group Company has otherwise become directly or indirectly liable, in each case, except any indebtedness or liability incurred since November 1, 2024 in the ordinary course of business consistent with past practices and/or any indebtedness or liability incurred pursuant to this Agreement.

Section 3.10. Operations.

The Buyer Group Companies have good and marketable title to all real property and other properties owned by them that is material to the business of the Buyer Group Companies taken as a whole, in each case free and clear of all Liens, except for Liens that do not materially affect the value of such property and do not materially interfere with the use made and proposed to be made of such property by the Buyer Group Companies. Any real property and facilities held under lease by the Buyer Group Companies that are material to the business of the Buyer Group Companies are held by the Buyer Group Companies under valid, subsisting and enforceable leases with which the Buyer Group Companies are in compliance in all material respects.

Section 3.11. Absence of Certain Changes.

Since September 30, 2024, (a) the Buyer has not altered its method of accounting, and (b) the Buyer has not declared or made any dividend or distribution of cash or other property to its shareholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock.

Section 3.12. Litigation.

As of the date hereof, there is no Proceeding of any nature pending, or, to the Buyer’s Knowledge, threatened, in writing against the Buyer or any of its Subsidiaries, or, to the Buyer’s Knowledge, any of their respective directors or officers in their capacities as such, which would, individually or in the aggregate, have a Buyer Material Adverse Effect.

Section 3.13. Bankruptcy.

The Buyer is not the subject of any insolvency or liquidation Proceeding or any reorganization in any jurisdiction.

Section 3.14. Brokers’ Fees.

There is no investment banker, broker, finder or other intermediary which has been retained by or is authorized to act on behalf of the Buyer or any of its Subsidiaries who would be entitled to any fee or commission in connection with the transactions contemplated by this Agreement.

Section 3.15. No Buyer Material Adverse Effect.

There has been no event, occurrence, development or state of circumstances that has had, has or would reasonably be expected to, individually or aggregately, result in a Buyer Material Adverse Effect.

Section 3.16. Independent Investigation.

The Buyer has conducted its own independent investigation, review and analysis of the business, operations, assets, liabilities, results of operations, financial condition and prospects of the Seller and the Target Co. Group Companies, which investigation, review and analysis was done by the Buyer and its Affiliates and representatives. In entering into this Agreement, the Buyer acknowledges that the Seller and its representatives have not made any representations, warranties, estimates or projections, and it has not relied on any representations, warranties, estimates or projections of the Seller or its representatives, other than the representations and warranties of the Seller set forth in ARTICLE 4.

Article 4
Representations and Warranties of the Seller

The Seller hereby represents and warrants, as of the date hereof and as of the Closing Date, that each of the following statements is true and correct:

Section 4.1. Accuracy of Disclosure.

The Seller has filed or furnished, as applicable, on a timely basis, all the SEC Documents. As of their respective effective dates (in the case of the SEC Documents that are registration statements filed pursuant to the requirements of the Securities Act) and as of their respective SEC filing dates (in the case of all other SEC Documents), or in each case, if amended prior to the date hereof, as of the date of the last such amendment: (a) each of the SEC Documents complied in all material respects with the applicable requirements of the listing and corporate governance rules and regulations, and (b) none of the SEC Documents contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the material statements therein, in the light of the circumstances under which they were made, not misleading.

Section 4.2. Existence and Power.

Each of the Seller and the Target Co. Group Companies is an entity duly organized or incorporated, validly existing and in good standing (to the extent such concept is applicable) under the laws of its jurisdiction of organization or incorporation and has full right, power and authority to execute and deliver this Agreement and each other Transaction Document to which it is or will be a party, to perform fully its obligations hereunder and thereunder and to consummate the transactions contemplated hereby and thereby. Each Target Co. Group Companies has the requisite corporate power and authorization to own, lease and operate its properties and to carry on its business as now being conducted, except which have not had and would not constitute a Target Co. Material Adverse Effect.

Section 4.3. Authorization; Due Execution.

Section 4.4. No Conflicts.

The execution, delivery and performance by each of the Seller and the Target Co. Group Companies of this Agreement and each other Transaction Document to which it is or will be a party and the consummation of the transactions contemplated hereby and thereby do not and will not (with or without the giving of notice, the lapse of time or both) conflict with or result in a violation or breach of, or default under, (a) its the Organizational Documents; (b) any Applicable Law to which it or any of its properties or assets is subject; (c) any contract, agreement or other instrument applicable to it or any of its properties or assets, except, in the case of clauses ‎(a) and ‎(b) above, to the extent that such conflict, violation, breach or default, individually or in the aggregate, has not impaired or delayed, and will not impair or delay, the ability of it to perform its obligations under this Agreement or any other Transaction Document to which it is a party or to consummate the transactions contemplated hereby or thereby.

Section 4.5. Capitalization.

(a) As of immediately prior to the Closing, the authorized share capital of the Target Co. consists of $50,000 divided into 50,000 ordinary shares of US$1.0 par value each, all of which are issued and outstanding. All of the issued and outstanding shares of the Target Co. are duly authorized, validly issued, fully paid and non-assessable and owned by the Seller as of immediately prior to the Closing.

(b) Except as otherwise set forth above in this Section 4.5, there are no outstanding (i) shares of capital stock or voting securities of Target Co., (ii) securities of Target Co. (whether debt or equity) convertible into or exchangeable for shares of capital stock or voting securities of Target Co., or (iii) preemptive or other outstanding rights, options, warrants, conversion rights, “phantom” stock rights, stock appreciation rights, redemption rights, repurchase rights, agreements, arrangements, calls, commitments or rights of any kind that obligate Target Co. to issue or sell any shares of capital stock or other securities of Target Co. or any securities or obligations convertible or exchangeable into or exercisable for, or giving any Person a right to subscribe for or acquire, any securities of Target Co., and no securities or obligations evidencing such rights are authorized, issued or outstanding, or (iv) obligations of Target Co. to repurchase, redeem or otherwise acquire any capital stock or equity interests of Target Co..

(c) Immediately after the Closing, the Buyer shall own the Sale Shares, which shall represent 100% of Target Co.’s then total issued and outstanding shares, on an as-converted and fully-diluted basis.

Section 4.6. Subsidiaries.

Each Subsidiary of Target Co. has been duly organized, is validly existing and in good standing (to the extent such concept is applicable) under the laws of its jurisdiction of organization or incorporation, and has the requisite corporate power and authorization to own, lease and operate its properties and to carry on its business as now being conducted, except which have not had and would not constitute a Target Co. Material Adverse Effect. Each Target Co. Group Company is duly qualified or licensed to do business in each jurisdiction in which the property owned, leased or operated by it or the nature of the business conducted by it makes such qualification or licensing necessary, except where the failure to be so qualified or licensed would not, individually or in the aggregate, reasonably be expected to have a Target Co. Material Adverse Effect.

Section 4.7. Compliance with Laws.

The business of Target Co. and its Subsidiaries is being conducted, and has been conducted at any time during the three (3) years prior to the date hereof, in all material respects in accordance with their respective Applicable Laws and other requirements of all Governmental Authorities having jurisdiction over or otherwise applicable to each of Target Co. and its Subsidiaries except as would not, individually or in the aggregate, result in a Target Co. Material Adverse Effect.

Section 4.8. Governmental Approvals.

The execution, delivery and performance by the Seller and Target Co. of this Agreement and any other Transaction Document to which it is or will be a party and the consummation of the transactions contemplated hereby and thereby do not and will not require any Approval issued or granted by, negative clearance from, or expiration or early termination of any waiting period imposed by, any Governmental Authority.

Section 4.9. Financial Matters.

(a) The financial statements of Target Co. Group Companies for the years ended [September 30, 2023 and September 30, 2024 (collectively, the “Financial Statements”) are attached to Section 4.9 of the Disclosure Letter, and present fairly and accurately the financial condition of Target Co. Group Companies as of the dates therein indicated and the results of operations for the period or periods therein specified, all in accordance with US GAAP on a consistent basis throughout the periods therein specified (except as otherwise noted therein). The information set forth in the Financial Statements is true and accurate in all material respects.

(b) Except as disclosed in the Financial Statements, none of Target Co. Group Companies is a guarantor or indemnitor of any indebtedness of any other person or entity, nor any Target Co. Group Company has any indebtedness or liability (contingent or otherwise) that it has directly or indirectly created, incurred, assumed, or guaranteed, or with respect to which such Target Co. Group Company has otherwise become directly or indirectly liable, in each case, except any indebtedness or liability incurred since November 1, 2024 in the ordinary course of business consistent with past practices and

Section 4.10. Operations.

Target Co. Group Companies have good and marketable title to all real property and other properties owned by them that is material to the business of Target Co. Group Companies taken as a whole, in each case free and clear of all Liens, except for Liens that do not materially affect the value of such property and do not materially interfere with the use made and proposed to be made of such property by Target Co. Group Companies. Any real property and facilities held under lease by Target Co. Group Companies that are material to the business of Target Co. Group Companies are held by Target Co. Group Companies under valid, subsisting and enforceable leases with which Target Co. Group Companies are in compliance in all material respects.

Section 4.11. Absence of Certain Changes.

Since October 1, 2024, (a) the Target Co. Group Companies has not altered its method of accounting, and (b) Target Co. has not declared or made any dividend or distribution of cash or other property to its shareholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock.

Section 4.12. Litigation.

As of the date hereof, there is no Proceeding of any nature pending, or, to the Seller’s Knowledge, threatened, in writing against Target Co. or any of its Subsidiaries, or, to the Seller’s Knowledge, any of their respective directors or officers in their capacities as such, which would, individually or in the aggregate, have a Target Co. Material Adverse Effect.

Section 4.13. Bankruptcy.

Target Co. is not the subject of any insolvency or liquidation Proceeding or any reorganization in any jurisdiction.

Section 4.14. Brokers’ Fees.

There is no investment banker, broker, finder or other intermediary which has been retained by or is authorized to act on behalf of the Target Co. or any of its Subsidiaries who would be entitled to any fee or commission in connection with the transactions contemplated by this Agreement.

Section 4.15. No Target Co. Material Adverse Effect.

There has been no event, occurrence, development or state of circumstances that has had, has or would reasonably be expected to, individually or aggregately, result in a Target Co. Material Adverse Effect.

Section 4.16. Independent Investigation.

The Seller has conducted its own independent investigation, review and analysis of the business, operations, assets, liabilities, results of operations, financial condition and prospects of the Buyer Group Companies, which investigation, review and analysis was done by the Seller and its Affiliates and representatives. In entering into this Agreement, the Seller acknowledges that the Buyer and its representatives have not made any representations, warranties, estimates or projections, and it has not relied on any representations, warranties, estimates or projections of the Buyer or its representatives, other than the representations and warranties of the Buyer set forth in ARTICLE 3.

Article 5
Conditions

Section 5.1. Conditions to the Obligation of the Seller and the Buyer to Consummate Closing.

As to each of the Seller and the Buyer, its obligations to consummate the Closing are subject to the satisfaction or waiver by it of the following conditions:

(a) no Applicable Law shall have been adopted, promulgated or enforced by any Governmental Authority, and no temporary restraining Order, preliminary or permanent injunction or other Order issued by any Governmental Authority of competent jurisdiction (an “Injunction”) shall be in effect, having the effect of making the transactions contemplated hereby illegal or otherwise prohibiting the consummation of the transactions contemplated hereby; and

(b) no Proceeding initiated by any Governmental Authority seeking an Injunction having the effect of making the transactions contemplated hereby illegal or otherwise prohibiting the consummation of the transactions contemplated hereby shall be pending.

Section 5.2. Other Conditions to the Obligation of the Seller to Consummate the Closing.

In addition to the conditions specified in Section 5.1 above, the Seller’s obligation to consummate the Closing is also subject to the fulfillment, on or prior to the Closing, of each of the following conditions (any or all of which may be waived by the Seller, in its sole discretion, in whole or in part to the extent permitted by Applicable Laws):

(a) each of the parties to the Transaction Documents, other than the Seller, shall have executed and delivered such Transaction Documents to the Seller;

(b) the representations and warranties set forth in Article 3 shall be true and correct in all material respects (other than the Fundamental Buyer Representations, which shall be true and correct in all respects) on and as of the date hereof and the Closing Date as if made on the Closing Date with reference to facts and circumstances then existing;

(c) the Buyer shall have performed and complied with, in all material respects, all agreements, obligations and conditions contained in this Agreement that are required to be performed or complied with by it on or before the Closing;

(d) the Buyer and its relevant Subsidiaries (if applicable) shall have obtained all relevant corporate and other Approvals and consents required to be obtained by them, including Approvals from any Governmental Authority, directors, creditors and third parties (if applicable) necessary for consummation of the transactions contemplated by this Agreement and any other Transaction Document, and the same shall not have been withdrawn or amended;

(e) there shall have been no Buyer Material Adverse Effect;

(f) no stop order suspending the qualification or exemption from qualification of Consideration Shares from trading on the NASDAQ shall have been issued and no Proceeding for that purpose shall have been commenced or shall be pending or threatened;

(g) the CSRC Filing Materials shall have been finalized and reasonably satisfactory to the Seller;

(h) the conditions to consummate the closing of the Share Transfer (as defined in the Equity Transfer Agreement as “交割”) shall have been satisfied or waived by the relevant parties; and

(i) the Buyer shall have delivered to the Seller a compliance certificate, dated the Closing Date and signed by an authorized representative of the Buyer, certifying that the conditions specified in Section 5.2 have been fulfilled.

Section 5.3. Other Conditions to the Obligation of the Buyer to Consummate the Closing.

In addition to the conditions specified in Section 5.1 above, the Buyer’s obligation to consummate the Closing is also subject to the fulfillment, on or prior to the Closing, of each of the following conditions (any or all of which may be waived by the Buyer, in its sole discretion, in whole or in part to the extent permitted by Applicable Laws):

(a) each of the parties to the Transaction Documents, other than the Buyer, shall have executed and delivered such Transaction Documents to the Buyer;

(b) the representations and warranties set forth in Article 4 shall be true and correct in all material respects (other than the Fundamental Seller Representations, which shall be true and correct in all respects) on and as of the date hereof and the Closing Date as if made on the Closing Date with reference to facts and circumstances then existing;

(c) the Seller shall have performed and complied with, in all material respects, all agreements, obligations and conditions contained in this Agreement that are required to be performed or complied with by it on or before the Closing;

(d) the Seller and Target Co. Group Companies shall have obtained all relevant corporate and other Approvals and consents required to be obtained by them, including Approvals from any Governmental Authority, directors, creditors and third parties (if applicable) necessary for consummation of the transactions contemplated by this Agreement and any other Transaction Document, and the same shall not have been withdrawn or amended;

(e) the Reorganization shall have been completed and each of RONS Intelligent, Shenzhen Xinbao, RONS Sales and Shenzhen Baowang shall have been the wholly Subsidiary of Target Co.;

(f) there shall have been no Target Co. Material Adverse Effect;

(g) the conditions to consummate the closing of the Share Transfer (as defined in the Equity Transfer Agreement as “交割”) shall have been satisfied or waived by the relevant parties; and

(h) the Seller shall have delivered to the Buyer a compliance certificate, dated the Closing Date and signed by an authorized representative of the Seller, certifying that the conditions specified in Section 5.3 have been fulfilled.

Article 6
Covenants

Section 6.1. Conduct of Business Pending the Closing.

During the period commencing from the date of this Agreement up to the earlier of (x) the Closing Date, and (y) the termination of this Agreement in accordance with Article 8 (the “Relevant Period”), Target Co. Group Companies shall use their commercially reasonable efforts to continue to engage in business in the ordinary and normal course, consistent with past practice. During the Relevant Period, except as consented to in writing by the Seller, the Buyer shall not (i) declare or make any dividend or distribution of cash or other property to its shareholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock, or (b) issue any equity securities to any officer, director, employee or Affiliate of the Buyer and its Subsidiaries, except pursuant to existing stock option plans.

Section 6.2. Notification.

Target Co. and the Seller shall notify the Buyer, and the Buyer shall notify each of Target Co. and the Seller, promptly upon becoming aware of (A) any material adverse change in the business, operations, assets or financial condition of Target Co. Group Companies or the Buyer Group Companies, (B) any material breach of any major contract or material default under any material commitment or arrangement to which any Target Co. Group Company or any Buyer Group Company is a party, (C) any litigation, arbitration, administrative or other proceeding concerning or affecting any Target Co. Group Company or any Buyer Group Company which is current, threatened or pending and is or would reasonably be expected to be material to the Target Co. Group Companies taken as a whole or the Buyer Group Companies taken as a whole, (D) any event, circumstance or matter which has had or is reasonably likely to have a Target Co. Material Adverse Effect or Buyer Material Adverse Effect, as the case may be, and/or (E) any event, circumstance or matter which has caused or is reasonably likely to cause any breach of any representation, warranty, covenant or agreement in respect of Target Co. / the Seller or the Buyer.

Section 6.3. Required Consents; Communications with Governmental Authorities.

(a) Subject to the terms and conditions of this Agreement, each Party shall use its reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary or desirable under Applicable Laws to consummate the transactions contemplated by this Agreement and any other Transaction Document, including (i) determining whether any approval, consent, registration, permit, authorization, other confirmation, waiver or other action from or by any Governmental Authority or counterparty to any contract of such Party is necessary or advisable in connection with the consummation of the transactions contemplated by this Agreement or any other Transaction Document (collectively, “Required Consents”); (ii) taking any actions in respect of, giving any notice to and preparing and making any filings with, any Governmental Authority or other third party in respect of any Required Consent as promptly as practicable following the date hereof and furnishing all information or other documentation required in connection with such action, notice or filing; and (iii) taking such further steps as may be required to timely obtain and maintain each Required Consent, including by using reasonable best efforts to obtain the early termination of any applicable waiting period.

(b) To the extent permitted by Applicable Laws or any relevant Governmental Authority, and subject to all applicable privileges, including the attorney-client privilege, each Party shall (i) give to the other Parties prompt notice upon obtaining knowledge of the making or commencement of any request, inquiry or Proceeding by or before any Governmental Authority with respect to the transactions contemplated hereby or by any other Transaction Document; (ii) keep the other Parties informed as to the status of any such request, inquiry or Proceeding; and (iii) promptly inform the other Parties of any communication to or from any Governmental Authority regarding the transactions contemplated hereby or by any other Transaction Document. Each Party shall consult and cooperate with, and consider in good faith the views of, the other Parties (to the extent practicable) throughout any defense of the transactions contemplated by this Agreement and any other Transaction Document.

(c) The Buyer shall (i) prepare for the application documents and other materials for the submission of the CSRC Filing (the “CSRC Filing Materials”), where the Seller and the Target Co. Group Companies shall use their commercially reasonable efforts to provide necessary information related to themselves, in connection with the preparation for the CSRC Filing Materials and making of the submission of the CSRC Filing, and (ii) provide the drafts of the CSRC Filing Materials to the Seller and consider in good faith the reasonable comments made by the Seller to such CSRC Filing Materials; and (iii) provide the Seller with final version of the CSRC Filing Materials which is reasonably satisfactory to the Seller prior to the Closing Date; and (iv) duly submit the CSRC Filing on the Closing Date; and (v) discuss with the Seller in good faith, and resolve any investigation or other inquiry of any Governmental Authority in connection therewith; and (vi) complete the CSRC Filing in due course.

Section 6.4. Confidentiality.

Each Party (the “Recipient”) shall keep confidential, shall cause its Affiliates, and its and their respective counsels, financial advisors, auditors and other authorized representatives, including, without limitation, their agents, employees, officers, and directors (collectively, the “Representatives”) to keep confidential, the existence of the Transaction Documents and the transactions contemplated under the Transaction Documents, the negotiations relating to any Transaction Document, and the terms and conditions hereof and of any other Transaction Document, and any non-public information relating to any other Party and its Representatives (collectively, the “Confidential Information”) except as such other Parties agree in writing otherwise; provided that the Recipient may disclose any Confidential Information (i) to the extent that such disclosure is required by Applicable Laws and/or the rules of any stock exchange, and so long as, where such disclosure is to a Governmental Authority or stock exchange, such Party shall use all reasonable efforts to obtain confidential treatment of the Confidential Information so disclosed, to the extent permissible under the Applicable Laws and/or the rules of any stock exchange, or (ii) to its professional advisors participating in the negotiation and implementation of the Transaction Documents so long as each such professional advisor to whom the Confidential Information is so disclosed agree to keep such Confidential Information confidential, or (iii) to its Representatives as necessary to the performance of its obligations in connection with any Transaction Document, in each case so long as each such Person to whom the Confidential Information is so disclosed agrees to keep such Confidential Information confidential.

Section 6.5. Further Assurances.

The Parties shall take all reasonable actions and provide all such reasonable assurances as may be required to consummate the transactions contemplated by this Agreement and any other Transaction Document, and each Party shall provide such further documents or instruments reasonably required by any other Party or desirable to effect the purposes of this Agreement and any other Transaction Document and to carry out their respective provisions. For the avoidance of doubt, nothing in this Section 6.5 shall be construed to be obligated to waive the relevant conditions precedent to its obligations to consummate the Closing, which shall be determined by each of the relevant Parties at its sole discretion and not be subject to this Section 6.5.

Section 6.6. Public Announcements.

The Parties will, to the extent permitted by Applicable Laws, consult with each other before issuance, and provide each other with the opportunity to review, comment on, and use all reasonable efforts to agree on, any press release or other public disclosure with respect to this Agreement and the other Transaction Documents and the transactions contemplated hereby and thereby, and will not (to the extent practicable) issue any such press release or make any such public disclosure prior to such consultation and agreement, except that disclosure made by a Party without having reached such agreement despite consultation shall be permissible if the substance and timing of the disclosure are necessary to comply with the Applicable Laws or an applicable securities exchange rules and regulations, provided that the disclosing Party shall, to the extent permitted by Applicable Laws or the applicable securities exchange rules and regulations and if reasonably practicable, inform the other Parties of the disclosure to be made pursuant to such requirements prior to the disclosure. Subject to Applicable Laws, the Parties shall use all reasonable efforts to promptly provide or cause to be promptly provided information and documents as requested by the NASDAQ, the SEC, the CSRC or any other competent Governmental Authority or that are necessary or advisable to comply with the Applicable Laws and the rules and regulations of any applicable securities exchange and permit consummation of the transactions contemplated hereunder.

Section 6.7. Tax.

All transfer, documentary, sales, use, stamp, registration, value added, and other such tax and fees (including any penalties and interest) incurred by and imposed on a Party in connection with this Agreement shall be borne and paid by such Party when due. Each Party shall, if applicable, at its own expense, timely file any Tax Return or other document with respect to such tax or fees.

Section 6.8. Non-Competition.

Within five (5) years after the Closing Date and subject to that the Buyer directly and indirectly owns 100% of total issued and outstanding shares of the Target Co., Shenzhen Xinbao, RONS Sales, Shenzhen Baowang and RONS Intelligent, (1) the Seller shall not, either directly or indirectly, either on its own account or through any of its Affiliates, or in conjunction with or on behalf of any other Person, (i) engage in any business that directly competes with the principal business of the Target Co. as now being conducted (i.e., the development of insurance transaction systems) (such business, the “Principal Business”), (ii) solicit or entice away, any employee of Target Co. Group Companies, to an entity which directly competes with the Principal Business engaged by any Group Company, and/or (iii) solicit or entice away, any client or customer of Target Co. Group Companies, to an entity which directly competes with the Principal Business engaged by any Group Company for the purpose of offering such client or customer any goods or services within the scope of the Principal Business; and (2) with respect to the Principal Business, the Target Co. Group Companies shall have priority to cooperate with the Seller under the same conditions and terms, where if the Seller has any transaction opportunities related to the Principal Business, it shall entrust such transaction opportunities to the Target Co. Group Companies under the same conditions and terms.

Section 6.9. Performance.

Subject to the conditions that the Seller retains Control over the business operations of the Target Co. Group Companies, the Seller shall use its commercially reasonable efforts to achieve the following performance milestone:

(a) The Target Co. Group Companies not to incur any losses during the financial years 2025 to 2027;

(b) RONS Intelligent and its Subsidiaries (if any), taken as a whole, to achieve the following minimum numbers of paying customers for each respective year: (i) not less than 100,000 paying customers in the year 2025; (ii) not less than 300,000 paying customers in the year 2026; (iii) not less than 900,000 paying customers in the year 2027;

(c) RONS Intelligent and its Subsidiaries (if any), taken as a whole, achieve the following objectives in relation to C-end users: (i) in the year 2026, the number of C-end users shall reach 100,000, and at least 10,000 proposals shall be issued; (ii) in the year 2027, the number of C-end users shall reach 500,000, and at least 50,000 proposals shall be issued.

However, it is expressly understood that the Seller shall not be liable for any failure to meet the above commitments if such failure is due to or resulting from any matters outside the Seller’s Control.

Section 6.10. Lock-Up.

Except (i) with the prior written consent of the Buyer; or (ii) transferring to its wholly-owned Subsidiary (in which case such transferee shall be bound by the similar lock-up provisions as hereof), the Seller shall not, directly or indirectly, transfer, sell, assign, pledge, or other disposal of any Consideration Share at any time on or before the expiry of a 60-month period after the Closing Date.

Article 7
Indemnification

Section 7.1. Survival.

(a) The Fundamental Seller Representations and the Fundamental Buyer Representations shall survive indefinitely or until the latest date permitted by Applicable Law.

(b) All representations and warranties contained in this Agreement other than the Fundamental Seller Representations and the Fundamental Buyer Representations, shall survive the Closing until eighteen (18) months following the Closing Date.

(c) Notwithstanding the foregoing clauses (a) and (b), any breach of any representation, warranty, covenant or agreement in respect of which indemnity may be sought under this Agreement shall survive the time at which it would otherwise terminate pursuant to the clauses (a) and (b) above, if notice of the inaccuracy or breach thereof giving rise to such right of indemnity shall have been given to the party against whom such indemnity may be sought prior to such time.

(d) Nothing contained in this Agreement shall limit or exclude any liability for fraud or willful misrepresentation.

Section 7.2. Indemnification by the Buyer.

Following the Closing, the Buyer shall indemnify and hold harmless the Seller and its Affiliates and their respective officers, directors, employees, agents, successors and assigns (each, a “Seller Indemnified Party”) for and against any and all Liabilities, losses, damages, claims, costs and expenses, interest, awards, judgments and penalties (including reasonable and documented attorneys’ and consultants’ fees and expenses) (each, a “Loss”) suffered or incurred by them (including any action brought or otherwise initiated by any of them), arising out of or resulting from:

(a) any breach or violation of, or inaccuracy in, any representation or warranty made by the Buyer under this Agreement or any claim by any third party alleging, constituting or involving such a breach, violation or inaccuracy; or

(b) any breach or violation of, or failure to perform, any covenants or agreements made by or on behalf of, or to be performed by, the Buyer under this Agreement or any claim by any third party alleging, constituting or involving such a breach, violation or failure to perform.

Section 7.3. Limits on Indemnification by the Buyer.

(a) The Buyer shall not be liable to the Seller Indemnified Parties for indemnification under ‎Section 7.2 until the aggregate amount of all Losses in respect of indemnification under Section 7.2 exceeds $3.0 million (the “Buyer Deductible”), in which event the Buyer shall only be required to pay or be liable for Losses in excess of the Buyer Deductible. With respect to any claim as to which a Seller Indemnified Party may be entitled to indemnification under Section 7.2, the Buyer shall not be liable for any individual or series of related Losses which do not exceed $3.0 million (which Losses shall not be counted toward the Buyer Deductible).

(b) In no event shall the Buyer be liable to any Seller Indemnified Party for any punitive, incidental, consequential, special, or indirect damages, including loss of future revenue or income, loss of business reputation or opportunity relating to the breach or alleged breach of this Agreement, or diminution of value or any damages based on any type of multiple.

(c) The maximum aggregate liability of the Buyer to the Seller Indemnified Parties with respect to all indemnification claims pursuant to this Section 7.2 shall not exceed $30.0 million.

(d) Payments by the Buyer pursuant to Section 7.2 in respect of any Loss shall be limited to the amount of any liability or damage that remains after deducting therefrom any insurance proceeds and any indemnity, contribution or other similar payment received or reasonably expected to be received by the Seller Indemnified Parties in respect of any such claim.

(e) Payments by the Buyer pursuant to Section 7.2 in respect of any Loss shall be reduced by an amount equal to any tax benefit realized or reasonably expected to be realized as a result of such Loss by the relevant Seller Indemnified Party.

Section 7.4. Indemnification by the Seller.

Following the Closing, the Seller shall indemnify and hold harmless the Buyer and its Affiliates and their respective officers, directors, employees, agents, successors and assigns (each, a “Buyer Indemnified Party”; the Buyer Indemnified Parties together with the Seller Indemnified Parties, collectively, the “Indemnified Parties”, and each, an “Indemnified Party”), for and against any and all Losses actually suffered or incurred by them (including any action brought or otherwise initiated by any of them), arising out of or resulting from:

(a) any breach or violation of, or inaccuracy in, any representation or warranty made by the Seller under this Agreement or any claim by any third party alleging, constituting or involving such a breach, violation or inaccuracy; or

(b) any breach or violation of, or failure to perform, any covenants or agreements made by or on behalf of, or to be performed by, the Seller under this Agreement or any claim by any third party alleging, constituting or involving such a breach, violation or failure to perform.

Section 7.5. Limits on Indemnification by the Seller.

(a) The Seller shall not be liable to the Buyer Indemnified Parties for indemnification under ‎Section 7.4 until the aggregate amount of all Losses in respect of indemnification under ‎Section 7.4 exceeds $3.0 million (the “Seller Deductible”), in which event the Seller shall only be required to pay or be liable for Losses in excess of the Seller Deductible. With respect to any claim as to which a Buyer Indemnified Party may be entitled to indemnification under Section 7.4, the Seller shall not be liable for any individual or series of related Losses which do not exceed $3.0 million (which Losses shall not be counted toward the Seller Deductible).

(b) In no event shall the Seller be liable to any Buyer Indemnified Party for any punitive, incidental, consequential, special, or indirect damages, including loss of future revenue or income, loss of business reputation or opportunity relating to the breach or alleged breach of this Agreement, or diminution of value or any damages based on any type of multiple.

(c) The maximum aggregate liability of the Seller to the Buyer Indemnified Parties with respect to all indemnification claims pursuant to this Section 7.4 shall not exceed $30.0million.

(d) Payments by the Seller pursuant to Section 7.4 in respect of any Loss shall be limited to the amount of any liability or damage that remains after deducting therefrom any insurance proceeds and any indemnity, contribution or other similar payment received or reasonably expected to be received by the Buyer Indemnified Parties in respect of any such claim.

(e) Payments by the Seller pursuant to Section 7.4 in respect of any Loss shall be reduced by an amount equal to any tax benefit realized or reasonably expected to be realized as a result of such Loss by the relevant Buyer Indemnified Party.

Section 7.6. Mitigation.

The Buyer, and the Seller shall take, and cause each applicable Indemnified Party to take, all reasonable steps to mitigate any Loss upon becoming aware of any event or circumstance that would be reasonably expected to, or does, give rise thereto, including incurring costs only to the minimum extent necessary to remedy the breach that gives rise to such Loss.

Section 7.7. Sole Remedy; Specific Performance.

Notwithstanding any other provision contained herein, the remedies contained in this Article 7 shall be the sole and exclusive monetary remedy of the Indemnified Parties for any claim arising out of or resulting from this Agreement, except that no limitation or exceptions with respect to the obligations or liabilities on any Party provided hereunder (including, without limitation, the limitations set forth in Section 7.3(a) and Section 7.5) shall apply to the extent that such Losses arise or are increased as the consequence of any fraud or willful misrepresentation by the Buyer or the Seller. Nothing in this Article 7 or elsewhere in this Agreement shall affect any Party’s rights to specific performance or other equitable or non-monetary remedies with respect to the covenants and agreements in this Agreement or that are to be performed at or after the Closing; provided that for the avoidance of doubt, except in the case of fraud, nothing contained herein shall permit any party to rescind this Agreement.

Section 7.8. Third Party Claims.

(a) If any third party shall notify an Indemnified Party in writing with respect to any matter involving a claim by such third party (a “Third Party Claim”) and such Indemnified Party believes such claim would give rise to a claim for indemnification against the Indemnifying Party under this Article 7, then the Indemnified Party shall promptly (i) notify the Indemnifying Party thereof in writing and (ii) transmit to the Indemnifying Party a written notice (“Claim Notice”) describing in reasonable detail, to the extent reasonably practicable, the nature of the Third Party Claim, a copy of all papers served with respect to such claim (if any), and the basis of the Indemnified Party’s request for indemnification under this Agreement. The failure to so notify the Indemnifying Party shall not relieve the Indemnifying Party of its obligations hereunder.

(b) Upon receipt of a Claim Notice with respect to a Third Party Claim, the Indemnifying Party shall have the right to assume the defense of any Third Party Claim by, within thirty (30) days of receipt of the Claim Notice, notifying the Indemnified Party in writing that the Indemnifying Party elects to assume the defense of such Third Party Claim, and upon delivery of such notice by the Indemnifying Party, the Indemnifying Party shall have the right to control and settle the proceeding, provided that, (i) any such settlement or compromise shall be permitted hereunder only with the written consent of the Indemnified Party which consent shall not be unreasonably withheld or delayed, and (ii) and the Indemnifying Party shall keep the Indemnified Party reasonably informed of the progress of such defense on a regular basis.

(c) If requested by the Indemnifying Party, the Indemnified Party shall, at the sole cost and expense of the Indemnifying Party, cooperate with the Indemnifying Party and its counsel in contesting any Third Party Claim which the Indemnifying Party elects to contest, including the making of any related counterclaim against the person asserting the Third Party Claim or any cross complaint against any person. The Indemnified Party shall have the right to receive copies of all pleadings, notices and communications with respect to any Third Party Claim for which indemnity is sought under this Agreement, other than any privileged communications between the Indemnifying Party and its counsel, and shall be entitled, at its sole cost and expense, to retain separate co-counsel and participate in, but not control, any defense or settlement (except for its consent required under Section 7.8(b) above) of any Third Party Claim assumed by the Indemnifying Party pursuant to Section 7.8(b).

(d) In the event of a Third Party Claim for which the Indemnifying Party elects not to assume the defense or fails to make such an election within thirty (30) days of the Claim Notice, the Indemnified Party may, at its option, defend, settle, compromise or pay such action or claim at the expense of the Indemnifying Party; provided that, any such settlement or compromise shall be permitted hereunder only with the written consent of the Indemnifying Party, which consent shall not be unreasonably withheld or delayed.

Article 8
Termination

Section 8.1. Termination Rights.

This Agreement may be terminated at any time prior to the Closing:

(a) by the mutual written consent of the Buyer or the Seller;

(b) by the Buyer or the Seller, if the Closing has not occurred by the Long Stop Date, provided that any such Party whose breach of any provision of this Agreement would give rise to the failure of the Closing to have been occurred by the Long Stop Date shall not have the right to terminate this Agreement; or

(i) there shall be any Applicable Law that makes consummation of the transactions contemplated by this Agreement illegal or otherwise prohibited; or

(ii) any Governmental Authority shall have issued an Order restraining or enjoining the transactions contemplated by this Agreement, and such Order shall have become final and non-appealable.

Section 8.2. Effects.

If this Agreement is terminated as provided under this Section 8.1, this Agreement will be of no further force or effect upon termination; provided that (i) the termination will not relieve any Party from any liability for any antecedent breach of this Agreement, and (ii) Section 6.4, Section 6.6, Section 6.7, Article 7, Section 8.2, Section 9.2, Section 9.6, ‎Section 9.7, Section 9.8, ‎Section 9.9 and Section 9.12 shall survive the termination of this Agreement.

Article 9
Miscellaneous

Section 9.1. Entire Agreement.

This Agreement and other Transaction Documents constitute the entire agreement between the Parties with respect to the subject matter hereof and thereof and supersede and cancel all prior agreements, understandings, representations and warranties, both oral and written, between the Parties with respect thereto, and there are no agreements, undertakings, representations or warranties of any of the Parties with respect to the transactions contemplated hereby and thereby other than those set forth herein or therein or made hereunder or thereunder.

Section 9.2. Notices.

Any notices, requests, claims, demands and other communications under this Agreement shall be in writing and shall be given or made (and shall be deemed to have been duly given or made upon receipt) by delivery in person, by next-day or second-day courier service, or by electronic mail to the respective Parties at the following addresses:

if to the Buyer:

Address:

No. 152 Hongliang East 1st Street, No. 1703,

Tianfu New District, Chengdu, 610200, PRC

	Phone:	+86-028-64775180
	E-mail:	xinchen@qiliancorp.com
	Attention:	Chen Xin

if to the Seller:

Address:

61F, Pearl River Tower, No. 15 Zhujiang West

Road, Zhujiang New Town, Tianhe, Guangzhou, PRC

	Phone:	+86 (20) 8388-3191
	E-mail:	gepeng@aifugroup.com
	Attention:	Ge Peng

if to Target Co. Group Companies:

Prior to the Closing:

Address:

61F, Pearl River Tower, No. 15 Zhujiang West

Road, Zhujiang New Town, Tianhe, Guangzhou, PRC

	Phone:	+86 (20) 8388-3191
	E-mail:	gepeng@aifugroup.com
	Attention:	Ge Peng

Upon and after the Closing:

Address:

No. 152 Hongliang East 1st Street, No. 1703,

Tianfu New District, Chengdu, 610200, PRC

	Phone:	+86-028-64775180
	E-mail:	xinchen@qiliancorp.com
	Attention:	Chen Xin

Where a notice is sent by delivery in person, such notice shall be deemed received upon the delivery. Where a notice is sent by next-day or second-day courier service, such notice shall be deemed received by properly addressing, pre-paying and sending by next-day or second-day service through an internationally-recognized courier a letter containing the notice, with a written confirmation of delivery, at the earlier of (i) delivery (or when delivery is refused) and (ii) expiration of three (3) Business Days after the letter containing the same is sent as aforesaid. Where a notice is sent by electronic mail, such notice shall be deemed received by properly addressing, with a written confirmation of delivery, and on the day the same is sent as aforesaid, if such day is a Business Day and if sent during normal business hours of the recipient, otherwise the next Business Day. Notwithstanding the foregoing, to the extent a “with a copy to” address is designated, notice must also be given to such address in the manner above for such notice, request, consent or other communication hereunder to be effective.

Each Party shall notify each other Party of any change to its name, appropriate addressee, address or e-mail address for the purposes of this ‎Section 9.2 by delivering a notice in accordance with the terms of this ‎Section 9.2.

Section 9.3. Amendment; Waiver.

This Agreement may be amended only by a written instrument executed by each of the Parties. References herein to this Agreement shall include any amendment or renewal hereof. Any Party may waive any right of such Party under this Agreement by an instrument signed in writing by such Party. Except as specifically provided herein, the failure or delay of any Party to enforce at any time any of the provisions of this Agreement shall in no way be construed to be a waiver of any such provision or to affect the validity of this Agreement or any part hereof or the right of any Party thereafter to enforce each such provision. No waiver of any breach of, or non-compliance with, this Agreement shall be deemed a waiver of any other or subsequent breach or non-compliance. Except as specifically provided herein, all remedies, either under this Agreement or under Applicable Laws or otherwise afforded, shall be cumulative and not alternative.

Section 9.4. Severability.

Every provision of this Agreement is intended to be severable. If any term or provision hereof is declared or held illegal or invalid, in whole or in part, for any reason whatsoever, such illegality or invalidity shall not affect the validity or enforceability of the remainder of the Agreement, and such provision shall be deemed amended or modified only to the extent necessary to cure such illegality or invalidity. Upon such determination of illegality or invalidity, the Parties shall negotiate in good faith to amend this Agreement to effect the original intent of the Parties. The invalidity or unenforceability of any provision of this Agreement in any jurisdiction shall not affect the validity or enforceability of the remainder of this Agreement in that jurisdiction or the validity or enforceability of this Agreement, including that provision, in any other competent jurisdiction.

Section 9.5. Non-assignment.

The provisions of this Agreement shall be binding upon and inure to the benefit of the Parties and their respective successors and permitted assigns; provided that neither this Agreement nor any right, remedy or Liability arising hereunder or by reason hereof may be assigned, delegated or otherwise transferred by any Party to any Person without the prior written consent of each other Party, except to any Affiliate (in which case such Party and its applicable Affiliate shall each be jointly and severally liable for their respective obligations) of such Party. Any assignment in violation of this Section 9.5 shall be null and void and of no effect.

Section 9.6. Governing Law.

This Agreement shall be governed by and construed in accordance with the laws of Hong Kong, without regard to its principles of conflicts of laws.

Section 9.7. Dispute Resolution.

(a) Any dispute arising out of or in connection with this Agreement, including any question regarding its existence, validity or termination, shall be referred to and finally resolved by arbitration administered by the Hong Kong International Arbitration Centre (HKIAC) under the HKIAC Administered Arbitration Rules (the “HKIAC Rules”) in force when the notice of arbitration is submitted in accordance with the HKIAC Rules. The HKIAC Rules are deemed to be incorporated by reference to this clause. The tribunal shall be comprised of three (3) arbitrators. The claimant and respondent shall each nominate one (1) arbitrator and the third, who shall serve as president of the tribunal, shall be nominated by the Party-nominated arbitrators. The arbitration shall be conducted in English. Each Party irrevocably and unconditionally consents to such arbitration as the sole and exclusive method of resolving any dispute arising out of or in connection with this Agreement, including any question regarding its existence, validity or termination, other than any proceedings to seek the remedies of specific performance as contemplated by ‎‎Section 9.9.

(b) The award of the arbitral tribunal shall be final and binding on the Parties. The Parties agree that they will not have recourse to any judicial proceedings, in any jurisdiction whatsoever, for the purpose of seeking appeal, annulment, setting aside, modification or any diminution or impairment of its terms or effect insofar as such exclusion can validly be made. Judgment upon any award rendered may be entered in any court having jurisdiction thereof, or application may be made to such court for a judicial acceptance of the award, injunction and an Order of enforcement, as the case may be.

Section 9.8. Performance Pending Dispute Resolution.

Unless otherwise terminated in accordance with the terms hereof, this Agreement and the rights and obligations of the Parties hereunder shall remain in full force and effect during the pendency of any proceeding under ‎‎Section 9.7.

Section 9.9. Specific Performance.

The Parties acknowledge and agree that irreparable damage would occur if any provision of this Agreement were not performed in accordance with the terms hereof and that, prior to the termination of this Agreement in accordance with ‎‎‎‎Section 9.7, each Party shall be entitled to specific performance of the terms hereof. It is accordingly agreed that prior to such termination, each Party shall be entitled to an injunction or injunctions to prevent such breaches of this Agreement and to enforce specifically (without proof of actual damages or harm, and not subject to any requirement for the securing or posting of any bond in connection therewith) such terms and provisions of this Agreement, this being in addition to any other remedy to which each Party is entitled at law or in equity.

Section 9.10. Counterparts.

This Agreement may be executed in any number of counterparts and by the Parties on separate counterparts, each of which shall be an original but all of which together shall constitute one and the same instrument. A “PDF” signature shall be considered due execution and shall be binding upon the signatory thereto with the same force and effect as if the signature were an original.

Section 9.11. Third-Party Beneficiaries.

Except as otherwise expressly set forth in this Agreement, there are no third-party beneficiaries of this Agreement and nothing in this Agreement, express or implied, is intended to confer on any third party any rights, remedies or obligations.

Section 9.12. Expenses.

Except as otherwise expressly set forth in this Agreement, each Party shall bear the taxes, costs and expenses incurred by it in connection with negotiating this Agreement and any other Transaction Document and in preparing and implementing this Agreement, any other Transaction Document and the transactions contemplated hereby and thereby.

[Remainder of Page Intentionally Left Blank]

IN WITNESS WHEREOF, the Parties have executed this Agreement as of the date first written above.

BGM Group Ltd

By:
	Name:
	Title:	director

[Signature page to Transaction Agreement]

IN WITNESS WHEREOF, the Parties have executed this Agreement as of the date first written above.

CISG Holding Ltd

By:
	Name:
	Title:	director

[Signature page to Transaction Agreement]

IN WITNESS WHEREOF, the Parties have executed this Agreement as of the date first written above.

Patriton Limited

By:
	Name:
	Title:	director

GM Management Company Limited

By:
	Name:
	Title:	director

RONS Intelligent Technology (Beijing) Co., Ltd. (榕数智能科技（北京）有限公司) (Seal)

By:
	Name:	Li Jun (李军)
	Title:	legal representative

[Signature page to Transaction Agreement]

EXHIBIT A
INSTRUMENT OF TRANSFER

[To be attached separately]

[Exhibits to Transaction Agreement]

EXHIBIT B
EQUITY TRANSFER AGREEMENT

[To be attached separately]

[Exhibits to Transaction Agreement]

Fanhua (NASDAQ:FANH)
Historical Stock Chart
From Nov 2024 to Dec 2024

Fanhua (NASDAQ:FANH)
Historical Stock Chart
From Dec 2023 to Dec 2024

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

FANH Fanhua Inc

Latest FANH Messages

Loading Messages....

Fanhua Inc News

Loading Messages....

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

FANH Fanhua Inc

Latest FANH Messages

Loading Messages....

Fanhua Inc News

Loading Messages....

Your Recent History

Company

Business

Popular

Get The App

Go Ad-Free